« Previous
Next »
Pediatric Neurology
Volume 30, Issue 3
, Pages 163-168
, March 2004
Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion
References
- . Hip dislocation in spastic cerebral palsy (Long-term consequences). J Pediatr Orthop. 1987;7:268–276
- . The hip in cerebral palsy. Dev Med Child Neurol. 1995;37:3–18
-
.
Management of hip disorders in patients with cerebral palsy.
J Am Acad Orthopaed Surg. 2002;10:198–209
- . The anatomy of the dysplastic hip in cerebral palsy related to prognosis and treatment. Int Orthop. 1985;9:105–110
- . The fate of the nonoperated hip in cerebral palsy. J Pediatr Orthop. 1987;7:262–267
- . Hip dysplasia in spastic cerebral palsy. Contemp Orthop. 1994;29:101–108
- . Hip dysplasia in bilateral cerebral palsy (Incidence and natural history in children aged 19 months to 5 years). Dev Med Child Neurol. 2001;43:586–600
- Intrathecal baclofen for management of spastic cerebral palsy (Multicenter trial). J Child Neurol. 2000;15:71–77
-
.
Childhood spasticity assessment.
In:
Sindou MP, Abbott IR, Keravel Y editor. Neurosurgery for spasticity. New York: Springer-Verlag; 1991;p. 51–56
- . Age and migration percentage as risk factors for progression in spastic hip disease. Dev Med Child Neurol. 1995;37:449–455
PII: S0887-8994(03)00474-0
doi: 10.1016/j.pediatrneurol.2003.08.006
© 2004 Elsevier Inc. All rights reserved.
« Previous
Next »
Pediatric Neurology
Volume 30, Issue 3
, Pages 163-168
, March 2004
